DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

66.37 -1.38 (-2.03%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $66.37 -2.03%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.49
Previous Close $67.75
Daily Range $66.20 - $68.15
52-Week Range $22.25 - $77.80
Market Cap $7.9B
P/E Ratio -205.29
Dividend (Yield) $0.00 (0.0%)
Volume 1,751,394
Average Daily Volume 2,547,418
Current FY EPS -$0.79




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary

How to Invest Money in Biotech

If you want to invest money in biotech, you first need to understand what catalysts tend to determine biotech stock valuations, and what your three best pathways are to becoming a successful biotech investor.

Idera Pharmaceuticals: Is The Writing On The Wall?

Isis Pharmaceuticals' ISIS-TTR Effective in Extension Study - Analyst Blog

Alnylam Strengthens Its Clinical Case Once Again

Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, and Isis Pharma

Trade-Ideas: ISIS Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

CAR-T Therapy Stocks Hit Hard Following AACR Data

It's A Big Weekend For Biotech

Johnson & Johnson's Earnings: The Good, The Bad and The Ugly

Johnson & Johnson reported a mixed first-quarter this week. Here is what investors need to know going forward.

3 Biotech Stocks That May Disappear Before 2020

Our experts weigh in.

See More ISIS News...

ISIS's Top Competitors

ISIS $66.37 (-2.03%)
Current stock: ISIS
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB